Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market
March 15 2022 - 6:06PM
Business Wire
Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an
international medical cannabis company, today commenced the trading
of its common shares on The Nasdaq Capital Market under the ticker
symbol “AKAN”. The common shares closed their first day of trading
above the offering price at $10.50.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220315006324/en/
Bophelo Campus, Akanda Corp. (Photo:
Business Wire)
On March 14, 2022, the Company priced its underwritten public
offering (the "Offering") of 4,000,000 common shares at a public
offering price of $4.00 per share. The gross proceeds to the
Company from the Offering were $16,000,000, before deducting
underwriting discounts, commissions, and other expenses.
Boustead Securities, LLC acted as the lead underwriter for the
Offering.
The securities described above are being sold by Akanda pursuant
to a registration statement, as amended, filed by the Company with
the Securities and Exchange Commission (the "SEC"), which was
declared effective on March 14, 2022. The Offering has been made
only by means of a prospectus. A copy of the final prospectus
related to the Offering may be obtained, when available, from
Boustead Securities, LLC, via email: offerings@boustead1828.com or
by calling +1 (949) 502-4408 or standard mail at Boustead
Securities, LLC, Attn: Equity Capital Markets, 6 Venture, Suite
395, Irvine, CA 92618, USA. In addition, a copy of the final
prospectus relating to the Offering may be obtained via the SEC's
website at www.sec.gov.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. The
Company is building a seed-to-patient supply chain, connecting
patients in the UK and Europe with diverse products including
cannabis products cultivated at its competitively advantaged grow
operation in the Kingdom of Lesotho and with other trusted
third-party brands. Akanda’s initial portfolio includes Bophelo
Bioscience & Wellness, a GACP qualified cultivation campus in
the Kingdom of Lesotho in Southern Africa, and CanMart, a UK-based
fully licensed pharmaceutical importer and distributor which
supplies pharmacies and clinics within the UK.
Connect with Akanda: Email | Website | LinkedIn | Twitter |
Instagram
Cautionary Note Regarding
Forward-Looking Information and Statements
This press release contains certain "forward-looking
information" within the meaning of applicable Canadian securities
legislation and may also contain statements that may constitute
"forward-looking statements" within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Such forward-looking information and
forward-looking statements are not representative of historical
facts or information or current condition, but instead represent
only Akanda's beliefs regarding future events, plans or objectives,
many of which, by their nature, are inherently uncertain and
outside of Akanda's control. Generally, such forward-looking
information or forward-looking statements can be identified by the
use of forward-looking terminology such as "plans", "expects" or
"does not expect", "is expected", "budget", "scheduled",
"estimates", "forecasts", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or may contain statements that certain actions, events or results
"may", "could", "would", "might" or "will be taken", "will
continue", "will occur" or "will be achieved". Forward-looking
information may relate to anticipated events or results including,
but not limited to business strategy, product development and sales
and growth plans. The forward-looking information and
forward-looking statements contained in this press release are made
as of the date of this press release, and Akanda does not undertake
to update any forward-looking information and/or forward-looking
statements that are contained or referenced herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220315006324/en/
Investor Contact
Matt Chesler, CFA FNK IR ir@akandacorp.com
Media Contacts
United States: Annie Grant Allison + Partners
akanda@allisonpr.com
Europe: Imogen Saunders Irvine Partners
imogen@irvinepartners.co.uk
Underwriter Contact
Dan McClory, Head of Equity Capital Markets Boustead Securities,
LLC dan@boustead1828.com
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Apr 2023 to Apr 2024